跳至主要内容
临床试验/NCT04971850
NCT04971850招募中不适用

Sleep-Disordered Breathing and Neurocognitive Assessment in Children and Young Adults

Assistance Publique - Hôpitaux de Paris2 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2022年2月2日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,200
试验地点
2
主要终点
Quality of life

研究概览

简要总结

One of main problems in the management of sleep-disordered breathing (SDB) in children and young adults is their screening, and the absence or the weak correlation between clinical symptoms and polysomnography (PSG). It may be useful to use additional measures together with PSG to improve the detection and characterization of respiratory events during sleep and/or correlation with clinical signs of SDB.

The primary objective of the study is to determine whether psychological and neuropsychological test scores correlate with diagnostic PSG results.

详细描述

One of main problems in the management of sleep-disordered breathing (SDB) in children and young adults is their screening, and the absence or the weak correlation between clinical symptoms and polysomnography (PSG). It may be useful to use additional measures together with PSG to improve the detection and characterization of respiratory events during sleep and/or correlation with clinical signs of SDB.

In addition, the clinical impact of SDB and the benefit of treatment are still not clear in children and young adults, including neurocognitive and developmental perspective.

Finally, the validation of simplified tools could optimize and simplify the detection of SDB in children and young adults.

Patients scheduled to perform a diagnostic PSG for routine clinical care will have additional recordings and questionnaires as part of the study.

The primary objective of the study is to determine whether psychological and neuropsychological test scores correlate with diagnostic PSG results.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
1 Year 至 20 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 1 to 20 years with a suspicion of SDB or a high-risk of SDB due to their pathology and hospitalized at Necker Hospital for a sleep study
  • Written informed consent

排除标准

  • No social insurance
  • Significant psychomotor retardation
  • Cooperation not possible
  • Significant agitation
  • Acute condition and/or temporary drug treatments that may interfere with the results of PSG (upper or lower airway infection)
  • Patient under guardianship/curatorship

结局指标

主要结局

Quality of life

时间窗: The day after the P(S)G

Quality of life questionnaire using the Pediatric Quality of Life Inventory (PedsQL). The higher the score, the better the quality of life. Min value = 0. Max value = 100.

Griffiths-III score

时间窗: The day after the P(S)G

Neurodevelopment evaluation using the Griffiths-III. Mean normal score is 100 ± 15. Abnormal for a score \<70.

Depression

时间窗: The day after the P(S)G

Depression questionnaire using the Multiscore Depression Inventory for Children (MDI-C), with an abnormal score being defined by a T-score ≥70. Mean normal value of T-score is 50 ± 10.

Trail Making test score

时间窗: The day after the P(S)G

Executive function evaluation using the Trail Making test. Mean normal score is 10 ± 3, abnormal for a score \<4.

WPPSI-IV score

时间窗: The day after the P(S)G

Neurodevelopment evaluation using the WPPSI-IV. Mean normal score is 100 ± 15. Abnormal for a score \<70.

NEPSY-II memory evaluation

时间窗: The day after the P(S)G

Memory evaluation using the NEPSY-II test. Mean normal score is 10 ± 3. Abnormal for a score \<4.

NEPSY-II score

时间窗: The day after the P(S)G

Executive function evaluation using the NEPSY-II. Mean normal score tests is 10 ± 3, abnormal for a score \<4.

KiTAP subtests score

时间窗: The day after the P(S)G

Executive function evaluation using the KiTAP subtests. Abnormal T-score \<30, with mean normal value of T-score is 50 ± 10.

WISC-V score

时间窗: The day after the P(S)G

Neurodevelopment evaluation using the WISC-V. Mean normal score is 100 ± 15. Abnormal for a score \<70.

Anxiety

时间窗: The day after the P(S)G

Anxiety questionnaire using the Revised Children's Manifest Anxiety Scale (RCMAS), with an anxiety being defined by a total T-score ≥60. Mean normal value of T-score is 50 ± 10.

Language

时间窗: The day after the P(S)G

Language evaluation using the Griffiths-III test. Mean normal score is 100 ± 15. Abnormal for a score \<70.

Sensoriality

时间窗: The day after the P(S)G

Sensoriality using the Sensory profile test. Atypical performance for a raw score \<122. Min value = 38. Max value = 190.

Children Memory Scale

时间窗: The day after the P(S)G

Memory evaluation using the Children Memory Scale test. Mean normal score is 10 ± 3. Abnormal for a score \<4.

Attention

时间窗: The day after the P(S)G

Attention evaluation using the TAP test. Abnormal for a T-score \<30. Mean normal value of T-score is 50 ± 10.

Behavior

时间窗: The day after the P(S)G

Behavior evaluation using the Child Behaviour Checklist (CBCL). Abnormal T-score \>65. Mean normal value of T-score is 50 ± 10.

次要结局

  • Alternative analysis in (pre-)teens(The day after baseline P(S)G)
  • Sleep disturbance(The day after baseline P(S)G)
  • Effect of treatment on WPPSI-IV score(At one year)
  • Effect of treatment on Pittsburgh Sleep Quality Index (PSQI)(At one year)
  • Effect of treatment on Epworth sleepiness scale (ESS)(At one year)
  • Effect of treatment on Griffiths-III score(At one year)
  • Effect of treatment on WISC-V score(At one year)
  • Correlations with pulse oximetry(The day after baseline P(S)G and 1 year after the intervention/procedure/surgery)
  • Correlations with clinical signs of SDB(The day after baseline P(S)G and 1 year after the intervention/procedure/surgery)
  • Correlations with sleep questionnaires(The day after baseline P(S)G and 1 year after the intervention/procedure/surgery)
  • Correlations with psychological and neuropsychological tests(The day after baseline P(S)G and 1 year after the intervention/procedure/surgery)
  • Alternative analysis(The day after baseline P(S)G)
  • Effect of treatment(At one year)
  • 3D facial surface analysis(The day after baseline P(S)G)
  • Changing detection of respiratory events(The day after baseline P(S)G and 1 year after the intervention/procedure/surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验